Certified by Founder Lodge
Hatteras Venture Partners
United States - Durham, NC
INVESTOR
1 Disclosed Funding Rounds $15,100,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Hatteras Venture Partners is a venture capital firm that builds transformational companies in the areas of biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related opportu
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 09 ,2022 | Series A | $15,100,000.00 |
| Company | Date | Round | Raised |
|---|---|---|---|
Cardiosense |
December, 09 ,2022 | Series A | $15,100,000 |
Mercy BioAnalytics, Inc. |
April, 04 ,2023 | Series A | $41,000,000 |
Aer Therapeutics, Inc. |
April, 17 ,2023 | Series A | $36,000,000 |
Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
Ten63 Therapeutics |
June, 16 ,2023 | Series A | $5,190,000 |
Elligo Health Research |
October, 03 ,2023 | Unknown | $40,000,000 |
iVEAcare, Inc. |
April, 23 ,2024 | Series A | $27,500,000 |
AtaCor Medical, Inc. |
April, 25 ,2024 | Series C | $28,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
Sensorium Therapeutics |
September, 03 ,2025 | Series A | $25,000,000 |
Boomerang Medical |
September, 04 ,2025 | Series B | $20,000,000 |
Cardiosense
Mercy BioAnalytics, Inc.
Aer Therapeutics, Inc.
Myeloid Therapeutics
Ten63 Therapeutics
Elligo Health Research
iVEAcare, Inc.
AtaCor Medical, Inc.
Endogenex
Atsena Therapeutics
Sensorium Therapeutics
Boomerang Medical
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)